The emergence and outbreak of the novel coronavirus SARS-CoV-2 at the end of 2019 has created an urgent need for testing to help limit the spread of COVID-19. AusDiagnostics has used its patented, multiplexed-tandem PCR technology to develop a test to detect SARS-CoV-2 and distinguish between the different causes of coronavirus-like infections.
The COVID-19 pandemic sweeping the globe has highlighted the need for the rapid development of new diagnostic tests, therapeutics and vaccines in response to emerging infectious diseases. Advanced gene assembly techniques represent a powerful tool to aid these efforts, and are currently allowing the construction of synthetic SARS-CoV-2 genomes for research and development activities. Codex DNA is at the forefront of this approach, using its knowhow and BioXp™ 3200 system to supply labs across the globe with the gene constructs required to accelerate the design and optimization of vaccines and treatments.
Spanish company Advanced Wave Sensors (AWSensors) is playing a key role in the pan-European Horizon 2020 LiqBiopSens and Catch-U-DNA projects to develop a new liquid biopsy platform for the early detection of colorectal and lung cancers. An important part of this process was the creation of a liquid handling platform incorporating an acoustic wave sensor array and microfluidic technology for the analysis of biomarkers in blood.
NGNY Devices is striving to fully automate laborious pre-analytical sample processing for clinical testing, helping to increase throughput and reduce human error. Its systems are already providing advanced sample sorting and aliquoting across Europe, offering a significant advantage over manual sample handling for busy clinical labs.
The specific detection of pathogens has a crucial role to play in ensuring control of infectious diseases. Scientists at F Cubed have developed a novel molecular analyzer – the NESDEP IU Molecular Diagnostic System – which relies on Tecan’s Cavro® Smart Valve and Cavro Centris Pump to offer straightforward identification of pathogens in a matter of minutes.
Rheonix Inc has integrated Tecan’s Cavro® Air Displacement Pipettor (ADP) into its EncompassMDx™ molecular diagnostics workstation, providing complete automation of sample processing and analysis using Rheonix’s CARD® molecular diagnostic technology.
Turkish company Zivak Technologies develops analytical kits and instrumentation for use in the food, healthcare and environmental sectors, and relies on Tecan’s Cavro® Omni Robot for its automated HPLC and LC-MCMS systems.